EyePoint Pharmaceuticals Ownership | Who Owns EyePoint Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

EyePoint Pharmaceuticals Ownership Summary


EyePoint Pharmaceuticals is owned by 98.54% institutional investors, 3.51% insiders. Cormorant asset management, lp is the largest institutional shareholder, holding 11.91% of EYPT shares. Federated Hermes Kaufmann R is the top mutual fund, with 2.96% of its assets in EyePoint Pharmaceuticals shares.

EYPT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEyePoint Pharmaceuticals98.54%3.51%-2.05%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cormorant asset management, lp8.32M11.91%$78.34M
Suvretta capital management6.80M9.73%$64.03M
Adage capital partners gp6.80M9.72%$63.99M
Blackrock funding, inc. /de5.36M7.67%$50.44M
Franklin resources4.14M7.60%$30.82M
Blackrock3.76M7.12%$32.75M
Vanguard group3.80M6.98%$28.33M
Federated hermes3.71M6.81%$27.62M
Tcg crossover management3.57M5.11%$33.62M
Morgan stanley2.25M4.26%$19.60M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cormorant asset management, lp8.32M5.84%$78.34M
Patient square capital lp1.35M4.59%$12.73M
Essex woodlands management1.17M3.94%$11.01M
Tcg crossover management3.57M3.84%$33.62M
Suvretta capital management6.80M1.93%$64.03M
5am venture management1.05M1.87%$7.82M
Blue owl capital lp562.59K1.71%$5.29M
Stempoint capital lp329.25K0.99%$3.10M
Bleichroeder lp256.51K0.59%$2.41M
Artia global partners lp216.70K0.58%$1.61M

Top Buyers

HolderShares% AssetsChange
Federated hermes3.71M0.06%1.78M
Blackrock3.76M0.00%977.52K
Morgan stanley2.25M0.00%910.68K
Abrdn1.03M0.02%800.46K
Vanguard group3.80M0.00%755.04K

Top Sellers

HolderShares% AssetsChange
Ra capital management---3.18M
Perceptive advisors---1.54M
Octagon capital advisors lp---1.09M
Finepoint capital lp---1.08M
Deerfield management company, l.p. (series c)---877.79K

New Positions

HolderShares% AssetsChangeValue
Granahan investment management340.98K0.13%340.98K$3.21M
Bleichroeder lp256.51K0.59%256.51K$2.41M
Caption management119.57K0.01%119.57K$1.13M
Hrt financial lp95.61K0.00%95.61K$899.00K
Bnp paribas arbitrage, snc86.81K0.00%86.81K$646.73K

Sold Out

HolderChange
Assetmark-15.00
Continuum advisory-16.00
Coldstream capital management-21.00
Park place capital-23.00
Principal securities-24.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025147-5.16%68,901,914-5.62%980.90%71-12.35%38-15.56%
Mar 31, 20251574.67%74,070,140-0.48%1060.57%81-16.49%4691.67%
Dec 31, 20241482.78%74,156,37726.76%1361.18%9541.79%24-52.00%
Sep 30, 2024143-8.92%58,500,9580.17%1070.88%68-26.09%489.09%
Jun 30, 2024157-10.29%58,402,7906.20%1101.02%92-21.37%4418.92%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Federated Hermes Kaufmann R2.04M2.96%-
Federated Hermes Kaufmann Growth2.04M2.96%-
Vanguard Total Stock Mkt Idx Inv2.03M2.94%-44.95K
Franklin Biotechnology Discv A(acc)USD1.91M2.77%-
Vanguard US Total Market Shares ETF1.56M2.27%-
Federated Hermes Kaufmann Small Cap A1.49M2.16%-125.99K
Federated Hermes Kaufmann Small Cap Grow1.49M2.15%-125.99K
iShares Russell 2000 ETF1.45M2.11%-27.61K
Franklin US Small Cap Growth Equity1.27M1.84%97.80K
Franklin Small Cap Growth SMA1.27M1.84%1.27M

Recent Insider Transactions


DateNameRoleActivityValue
May 16, 2025Zaderej Karen L.-Buy$29.05K
May 19, 2025Zaderej Karen L.-Buy$29.95K
May 14, 2025Zaderej Karen L.-Buy$27.10K
May 15, 2025Zaderej Karen L.-Buy$27.35K
Aug 20, 2024DICICCO WENDY F-Buy$20.00K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q24-
2025 Q1--
2024 Q341
2024 Q242

EYPT Ownership FAQ


Who Owns EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals shareholders are primarily institutional investors at 98.54%, followed by 3.51% insiders and -2.05% retail investors. The average institutional ownership in EyePoint Pharmaceuticals's industry, Biotech Stocks , is 306.59%, which EyePoint Pharmaceuticals falls below.

Who owns the most shares of EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals’s largest shareholders are Cormorant asset management, lp (8.32M shares, 11.91%), Suvretta capital management (6.8M shares, 9.73%), and Adage capital partners gp (6.8M shares, 9.72%). Together, they hold 31.36% of EyePoint Pharmaceuticals’s total shares outstanding.

Does Blackrock own EyePoint Pharmaceuticals?

Yes, BlackRock owns 7.12% of EyePoint Pharmaceuticals, totaling 3.76M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.75M$. In the last quarter, BlackRock increased its holdings by 977.52K shares, a 35.07% change.

Who is EyePoint Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Cormorant asset management, lp is EyePoint Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.84% of its assets in 8.32M EyePoint Pharmaceuticals shares, valued at 78.34M$.

Who is the top mutual fund holder of EyePoint Pharmaceuticals shares?

Federated Hermes Kaufmann R is the top mutual fund holder of EyePoint Pharmaceuticals shares, with 2.96% of its total shares outstanding invested in 2.04M EyePoint Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools